Vertex Pharmaceuticals Inc / Ma

Reynders McVeigh Capital Management, LLC VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/2/2026

Shares

53,905

Value ($000)

24,438

Weight

1.1%

2025 Q2 - 2025 Q4 (3 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/2/2026	24,438	1.1%	53,905	12/31/2025
2025 Q3	11/17/2025	21,677	1.0%	55,350	9/30/2025
2025 Q2	9/4/2025	24,179	1.2%	54,310	6/30/2025